We are live on ! Find out more
SGMT icon

Sagimet Biosciences
SGMT

88 hedge funds and large institutions have $69.8M invested in Sagimet Biosciences in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 18

52% more call options, than puts

Call options by funds: $1.72M | Put options by funds: $1.14M

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

2% more funds holding

Funds holding: 86 → 88 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4.73% less ownership

Funds ownership: 46.43% → 41.71% (-4.7%)

18% less capital invested

Capital invested by funds: $85.2M → $69.8M (-$15.5M)

Holders
88
Holders Change
+2
Holders Change %
+2.33%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
18
Increased
32
Reduced
18
Closed
13
Calls
$1.72M
Puts
$1.14M
Net Calls
+$586K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.58M
2
Millennium Management
Millennium Management
New York
+$1.53M
3
Marshall Wace
Marshall Wace
United Kingdom
+$1.04M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$753K
5
UBS Group
UBS Group
Switzerland
+$514K

Top Sellers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
-$5.07M
2
SL
Siren LLC
Connecticut
-$4.29M
3
AAA
Affinity Asset Advisors
New York
-$1.56M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$916K
5
Jane Street
Jane Street
New York
-$419K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFSG
76
Newbridge Financial Services Group
Florida
$7.84K – – –
NA
77
NewEdge Advisors
Louisiana
$5.59K +$5.96K +1,070 New
SAM
78
Smartleaf Asset Management
Massachusetts
$4.55K +$2.79K +500 +100%
PA
79
Parallel Advisors
California
$4.44K – – –
Federated Hermes
80
Federated Hermes
Pennsylvania
$4.08K +$2.89K +519 +198%
GFM
81
GF Fund Management
China
$3.6K +$451 +81 +13%
Northwestern Mutual Wealth Management
82
Northwestern Mutual Wealth Management
Wisconsin
$3.5K +$3.73K +670 New
MCM
83
MAI Capital Management
Ohio
$2.61K – – –
RWM
84
Rialto Wealth Management
New York
$1.88K – – –
PWA
85
Physician Wealth Advisors
Utah
$1.66K – – –
Fidelity Investments
86
Fidelity Investments
Massachusetts
$774 +$84 +15 +11%
AAP
87
Arax Advisory Partners
Colorado
$601 – – –
SS
88
SBI Securities
Japan
$439 +$334 +60 +250%
SL
89
Siren LLC
Connecticut
– -$4.29M -724,771 Closed
Verition Fund Management
90
Verition Fund Management
Connecticut
– -$916K -154,670 Closed
HighTower Advisors
91
HighTower Advisors
Illinois
– -$220K -37,189 Closed
LIP
92
Lighthouse Investment Partners
Florida
– -$135K -22,740 Closed
DekaBank Deutsche Girozentrale
93
DekaBank Deutsche Girozentrale
Germany
– -$125K -20,000 Closed
JFG
94
Jefferies Financial Group
New York
– -$78.2K -13,205 Closed
HLA
95
Hamilton Lane Advisors
Pennsylvania
– -$65.7K -11,095 Closed
WPC
96
Wedmont Private Capital
Pennsylvania
– -$59.6K -10,794 Closed
VF
97
Virtu Financial
New York
– -$62K -10,438 Closed
A
98
AlphaQuest
New York
– -$36.5K -6,174 Closed
AP
99
Antipodes Partners
Australia
– -$18.8K -3,176 Closed
VWA
100
VSM Wealth Advisory
Maryland
– -$8.88K -1,500 Closed
1 2 3
4
5

SGMT Hedge Fund Activity: Q1 2026 in Review

88 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sagimet Biosciences (SGMT) for Q1 2026, worth a combined $69.8M — down 18% from $85.2M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SGMT positions and 13 closed out — a net gain of 5 holders — while 32 added to existing stakes and 18 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.58M. The largest seller was Blue Owl Capital Holdings, cutting an estimated $5.07M.

  • 88 institutional investors held Sagimet Biosciences (SGMT) as of Q1 2026, up from 86 in Q4 2025.
  • Funds reported $69.8M of Sagimet Biosciences stock for Q1 2026, down 18% quarter-over-quarter.
  • 18 funds opened new Sagimet Biosciences positions in Q1 2026 and 13 closed out, a net change of +5 holders.
  • The largest Sagimet Biosciences buyer in Q1 2026 was Renaissance Technologies, an estimated $1.58M added.
  • The largest Sagimet Biosciences seller in Q1 2026 was Blue Owl Capital Holdings, an estimated $5.07M sold.

Based on aggregated 13F filings for Q1 2026.